Market capitalization | $2.50m |
Enterprise Value | $13.79m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.58 |
P/S ratio (TTM) P/S ratio | 0.10 |
P/B ratio (TTM) P/B ratio | 0.26 |
Revenue growth (TTM) Revenue growth | -13.23% |
Revenue (TTM) Revenue | $22.49m |
As a Free StocksGuide user, you can view scores for all 6,786 stocks worldwide.
Dec '23 |
+/-
%
|
||
Revenue | 22 22 |
13%
13%
|
|
Gross Profit | 6.66 6.66 |
24%
24%
|
|
EBITDA | -2.31 -2.31 |
800%
800%
|
EBIT (Operating Income) EBIT | -3.94 -3.94 |
201%
201%
|
Net Profit | -4.62 -4.62 |
167%
167%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. Its products include BioAstin natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health; and Spirulina Pacifica, a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
Head office | United States |
CEO | Matthew Custer |
Employees | 77 |
Founded | 1983 |
Website | www.cyanotech.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.